Study of Tazemetostat in combination with lenalidomide and rituximab compared to tazemetostat with placebo in participants with Relapsed/Refractory Follicular Lymphoma
A study to assess efficacy and safety of oral tazemetostat in adult participants with relapsed/refractory follicular lymphoma that does not have an “EZH2 gain-of-function” genetic mutation